TrialThe journal of nutrition, health & aging2013

A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.

D A Papanicolaou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.